Effect of the Semiconductor Quantum Dot Shell Structure on Fluorescence Quenching by Acridine Ligand
- Авторлар: Linkov P.A.1,2, Vokhmintcev K.V.1, Samokhvalov P.S.1, Laronze-Cochard M.3, Sapi J.3, Nabiev I.R.1,2
-
Мекемелер:
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
- Laboratory of Research in Nanosciences, LRN—EA4682
- Institute of Molecular Chemistry of Reims, Faculty of Pharmacy
- Шығарылым: Том 107, № 4 (2018)
- Беттер: 233-237
- Бөлім: Condensed Matter
- URL: https://ogarev-online.ru/0021-3640/article/view/160912
- DOI: https://doi.org/10.1134/S0021364018040070
- ID: 160912
Дәйексөз келтіру
Аннотация
The main line of research in cancer treatment is the development of methods for early diagnosis and targeted drug delivery to cancer cells. Fluorescent semiconductor core/shell nanocrystals of quantum dots (e.g., CdSe/ZnS) conjugated with an anticancer drug, e.g., an acridine derivative, allow real-time tracking and control of the process of the drug delivery to tumors. However, linking of acridine derivatives to a quantum dot can be accompanied by quantum dot fluorescence quenching caused by electron transfer from the quantum dot to the organic molecule. In this work, it has been shown that the structure of the shell of the quantum dot plays the decisive role in the process of photoinduced charge transfer from the quantum dot to the acridine ligand, which is responsible for fluorescence quenching. It has been shown that multicomponent ZnS/CdS/ZnS shells of CdSe cores of quantum dots, which have a relatively small thickness, make it possible to significantly suppress a decrease in the quantum yield of fluorescence of quantum dots as compared to both the classical ZnS thin shell and superthick shells of the same composition. Thus, core/multicomponent shell CdSe/ZnS/CdS/ZnS quantum dots can be used as optimal fluorescent probes for the development of systems for diagnosis and treatment of cancer with the use of anticancer compounds based on acridine derivatives.
Авторлар туралы
P. Linkov
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Laboratory of Research in Nanosciences, LRN—EA4682
Хат алмасуға жауапты Автор.
Email: valinkov@gmail.com
Ресей, Moscow, 115409; Reims, 51100
K. Vokhmintcev
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
Email: valinkov@gmail.com
Ресей, Moscow, 115409
P. Samokhvalov
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
Email: valinkov@gmail.com
Ресей, Moscow, 115409
M. Laronze-Cochard
Institute of Molecular Chemistry of Reims, Faculty of Pharmacy
Email: valinkov@gmail.com
Франция, Reims, 51100
J. Sapi
Institute of Molecular Chemistry of Reims, Faculty of Pharmacy
Email: valinkov@gmail.com
Франция, Reims, 51100
I. Nabiev
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Laboratory of Research in Nanosciences, LRN—EA4682
Email: valinkov@gmail.com
Ресей, Moscow, 115409; Reims, 51100
Қосымша файлдар
